Reference
NICE. PHARMAC funds new medicine (mepolizumab) for severe asthma. Internet Document : 12 Mar 2020. Available from: URL: https://www.pharmac.govt.nz/news/pharmac-funds-new-medicine-mepolizumab-for-severe-asthma/
Rights and permissions
About this article
Cite this article
New Zealand's PHARMAC funds mepolizumab for severe asthma. PharmacoEcon Outcomes News 849, 34 (2020). https://doi.org/10.1007/s40274-020-6685-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6685-9